Skip to content
Menu

Grifols, S.A. GRFS

Full chart Compare
Set alert

Price alert · GRFS

All alert types
8.15 USD -0.05 (-0.61%)

Regular-session close

8.14 -0.01 -0.12%

After hours · Nov 20, 4:31 PM ET

8.08 Day range 8.22
7.02 52-week range 9.72
YTD
-12.83%
1 year
-3.32%

Fundamental scorecard

18 of 25 checks passed on GRFS’s reported financials

ValueGrowthProfitabilityHealthDividend

18of 25 checks passed

  • Value 5 of 5
  • Growth 4 of 5
  • Profitability 4 of 5
  • Financial health 1 of 5
  • Dividend 4 of 5

Statements to Dec 31, 2025.

Value 5 of 5

  • Passed:P/E below its own 5-year median P/E 11.7 against a 5-year median of 31.3.
  • Passed:P/E under 20 P/E 11.7: an earnings yield of 8.5%.
  • Passed:Price to sales below its own 5-year median Price to sales 0.6 against a 5-year median of 0.9.
  • Passed:Price to book below its own 5-year median Price to book 0.9 against a 5-year median of 1.0.
  • Passed:Free cash flow yield above 4% Free cash flow of 363M is 7.7% of the market value.

Growth 4 of 5

  • Passed:Revenue grew over the last year Revenue of 7.52B is +4.3% on the year before.
  • Passed:Revenue grew more than 5% a year over five years +7.1% a year from FY 2020 to FY 2025.
  • Passed:Earnings per share grew over the last year EPS 0.59 against 0.23 in the year before.
  • Failed:Earnings per share grew more than 5% a year over five years -8.1% a year from FY 2020 to FY 2025.
  • Passed:Analysts expect higher earnings per share over the next year The average forward estimate is +49.9% on the last 12 months.

Profitability 4 of 5

  • Passed:Profitable over the last year Net income of 402M over FY 2025.
  • Passed:Profitable in each of the last five fiscal years A profit in 5 of the last 5 fiscal years.
  • Failed:Return on equity above 15% Return on equity of 7.2%.
  • Passed:Net margin above its 5-year average Net margin of 5.3% against a 5-year average of 3.0%.
  • Passed:Free cash flow is at least 80% of net income Free cash flow of 363M is 90.3% of net income.

Financial health 1 of 5

  • Passed:Short-term assets cover short-term liabilities Short-term assets of 5.07B against short-term liabilities of 2.02B.
  • Failed:Short-term assets cover long-term liabilities Short-term assets of 5.07B against long-term liabilities of 10.1B.
  • Failed:Net debt under 40% of equity Net debt of 8.78B is 166.6% of equity.
  • Failed:Operating cash flow covers at least 20% of debt Operating cash flow of 1.05B is 10.9% of debt.
  • Failed:Operating profit covers interest at least 3 times Operating profit is 1.8 times the interest expense.

Dividend 4 of 5

  • Passed:Pays a dividend 256M paid over FY 2025.
  • Passed:Yield above 1.5% A yield of 5.4% at the current market value.
  • Passed:Pays out under 75% of profit 63.7% of net income is paid out.
  • Passed:Covered by free cash flow 70.5% of free cash flow is paid out.
  • Failed:Not cut in the last five fiscal years The total paid fell in 2 of the last five fiscal years.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell. Amounts are in the company’s reporting currency.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What GRFS owns and owes, as of Dec 31, 2025

Short term and long term

Balance sheet · 19.7B of assets

Debt, equity and cash by year

Now: 8.78B of debt after cash

Fiscal years. Cash includes short-term investments.

From the company’s SEC filings, in its reporting currency.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

1.12 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

A-4 / 5 overall

  • DCF 4
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 1
  • P/E 3
  • P/B 4

Valuation

P/E 14.0×
P/S 0.7×
P/B 1.0×
P/FCF 7.2×
EV/EBITDA 8.2×
EV/Sales 1.8×
FCF Yield 13.9%

Profitability

Gross Margin 35.7%
Operating Margin 16.4%
Net Margin 5.3%
ROE 7.3%
ROIC 5.3%
ROA 2.0%

Growth (YoY)

Revenue 0.2%
Operating Income -0.4%
EPS (diluted) 147.8%
Free Cash Flow 41.5%

Financial Health

Current Ratio 2.5×
Quick Ratio 0.9×
Debt / Equity 1.7×
Net Debt / EBITDA 4.9×
Interest Coverage 2.0×

Dividends

Dividend Yield 2.3%
Payout Ratio 31.8%

Annual · latest fiscal year ends 2025-12-31